Severe Photosensitivity Reaction After Pirfenidone Use

Area of Science:

• Pulmonology
• Dermatology
• Pharmacology

Background:

• Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease with high mortality.
• Pirfenidone is an approved oral antifibrotic medication for IPF, shown to slow disease progression and preserve vital capacity.
• Widespread use of pirfenidone has increased in recent years for IPF management.

Observation:

• A 60-year-old male patient was initiated on pirfenidone treatment for IPF.
• The patient experienced severe skin reactions shortly after commencing pirfenidone therapy.

Findings:

• Pirfenidone, while effective in managing IPF, can cause significant cutaneous adverse events.
• This case highlights the potential for severe dermatological side effects associated with pirfenidone.

Implications:

• Clinicians should be vigilant for severe skin reactions in patients treated with pirfenidone for IPF.
• Further investigation into managing or predicting pirfenidone-induced skin toxicity may be warranted.
• This case underscores the importance of balancing treatment benefits with potential adverse effects in IPF management.